These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6785510)

  • 21. [Immunity parameters in children with prior intrathoracic tuberculosis].
    Elufimova VF; Mitinskaia LA; Iukhimenko NV; Romanova RIu; Abramova ZP; Dem'ianenko NV; Baenskiĭ AV
    Probl Tuberk; 2000; (2):23-5. PubMed ID: 10838903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Re-formulation of selected DNA vaccine candidates and their evaluation as protein vaccines using a guinea pig aerosol infection model of tuberculosis.
    Vipond J; Clark SO; Hatch GJ; Vipond R; Marie Agger E; Tree JA; Williams A; Marsh PD
    Tuberculosis (Edinb); 2006; 86(3-4):218-24. PubMed ID: 16520093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Some regularities of an immune response in patients with pulmonary tuberculosis and drug-resistant Mycobacterium strains].
    Sakharova IIa; Ariél' BM; Knoring BE; Skvortsova LA; Vasil'eva GIu; Vishnevskiĭ BI; Pogodaeva SS
    Probl Tuberk Bolezn Legk; 2008; (12):22-7. PubMed ID: 19230184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis.
    Kahnert A; Seiler P; Stein M; Bandermann S; Hahnke K; Mollenkopf H; Kaufmann SH
    Eur J Immunol; 2006 Mar; 36(3):631-47. PubMed ID: 16479545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity and protective efficacy of tuberculosis subunit vaccines expressing PPE44 (Rv2770c).
    Romano M; Rindi L; Korf H; Bonanni D; Adnet PY; Jurion F; Garzelli C; Huygen K
    Vaccine; 2008 Nov; 26(48):6053-63. PubMed ID: 18822333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Contemporary approach to the immunology of tuberculosis].
    Dudvarski-Ilić A
    Med Pregl; 2004; 57 Suppl 1():29-31. PubMed ID: 15686218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transmission and pathogenesis of tuberculosis.
    Bates JH
    Clin Chest Med; 1980 May; 1(2):167-74. PubMed ID: 7028370
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunological studies in the treatment of tuberculosis with flureniside].
    Sibirnaia RI
    Probl Tuberk; 1997; (5):27-8. PubMed ID: 9454246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Determination of immunological cellular reactions in pulmonary tuberculosis by phagocytosis of mycobacteria of varying virulence].
    Khmelevskaia GA
    Lab Delo; 1970; 10():601-5. PubMed ID: 4099563
    [No Abstract]   [Full Text] [Related]  

  • 30. Immune responses to sulpholipids of Mycobacterium tuberculosis H37 Rv.
    Mehta P; Khuller GK
    Indian J Med Res; 1987 Nov; 86():558-63. PubMed ID: 3132424
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pulmonary fibrosis caused by subintrant reactions of hypersensitivity to tuberculoprotein].
    Eskenasy A
    Ftiziologia; 1971; 20(1):25-32. PubMed ID: 5005703
    [No Abstract]   [Full Text] [Related]  

  • 32. [Tuberculosis: pathogenesis, immune responses and genetics of the host].
    Apt AS; Kondrat'eva TK
    Mol Biol (Mosk); 2008; 42(5):880-90. PubMed ID: 18988536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental pulmonary cavity formation by mycobacterial components and synthetic adjuvants.
    Yamamura Y; Maeda H; Ogawa Y; Hashimoto T
    Microbiol Immunol; 1986; 30(11):1175-87. PubMed ID: 3807794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inhibition of IgE antibody formation by tubercle bacilli and muramyl peptide].
    Kishimoto T
    Kekkaku; 1980 Oct; 55(10):467-70. PubMed ID: 6785511
    [No Abstract]   [Full Text] [Related]  

  • 35. [The structural and functional status of the immune system in pre-school children infected with Mycobacterium tuberculosis].
    Kurtasova LM; Prakhin EI; Shakina NA; Gorbacheva NN; Leshchenko OA
    Probl Tuberk Bolezn Legk; 2004; (1):31-2. PubMed ID: 15137143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Correlation of specific immune response and tuberculous changes in the lungs].
    Knoring BE; Feĭgin MI
    Probl Tuberk; 1993; (4):21-4. PubMed ID: 8127829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intratracheal administration of third-generation lentivirus vector encoding MPT51 from Mycobacterium tuberculosis induces specific CD8+ T-cell responses in the lung.
    Hashimoto D; Nagata T; Uchijima M; Seto S; Suda T; Chida K; Miyoshi H; Nakamura H; Koide Y
    Vaccine; 2008 Sep; 26(40):5095-100. PubMed ID: 18514976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevention of tuberculous cavity formation by desensitization with various mycobacterial compnents].
    Yamamura Y
    Kekkaku; 1968 Aug; 43(8):332-5. PubMed ID: 4974529
    [No Abstract]   [Full Text] [Related]  

  • 39. [Specific antitubercular immunity in patients with tuberculosis and other pulmonary abnormality: diagnostic value of its study].
    Adambekov DA; Kurmanov RA; Baenskií AV; Litvinov VI
    Probl Tuberk; 1997; (3):20-3. PubMed ID: 9265163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis.
    Andersen CS; Dietrich J; Agger EM; Lycke NY; Lövgren K; Andersen P
    Infect Immun; 2007 Jan; 75(1):408-16. PubMed ID: 17074845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.